Bookmark and Share

Last Minute: "Ex-cardinal McCarrick defrocked by Vatican for sexual abuse - The Washington Post" Sat, 16 Feb 2019 09:05:43 GMT    "Trump's border national emergency is more complicated than it looks - Washington Examiner" Fri, 15 Feb 2019 22:45:00 GMT    "Cash-strapped Pakistan rolls out red carpet for Saudis - BBC News" Sat, 16 Feb 2019 00:56:04 GMT    "U.S. Supreme Court to decide legality of census citizenship query - Reuters" Sat, 16 Feb 2019 02:38:00 GMT    "New York 9/11 survivors stunned by decision to slash compensation fund - New York Daily News" Fri, 15 Feb 2019 21:05:00 GMT    "Europe says it will stick with the Iran deal, defying a U.S. demand - The Washington Post" Fri, 15 Feb 2019 19:47:49 GMT   "Aurora Shooting Leaves 6 Dead, Including Gunman - WBEZ" Fri, 15 Feb 2019 20:41:00 GMT    "Houston officer apparently lied in seeking warrant before raid that left 2 dead, chief says - NBC News" Sat, 16 Feb 2019 05:03:17 GMT    "Sarah Sanders interviewed by Mueller's team in Russia probe - CNN" Sat, 16 Feb 2019 01:12:32 GMT    "San Jose police shooting: Abducted UPS driver hailed for thwarting carjackers during chase - The Mercury News" Fri, 15 Feb 2019 20:03:00 GMT      For more news, click here.

Authentication
       
       
Remember me? 


PS: The quotes after 2018-12-04 are still temporary and may have for that reason the Open values wrong until furter updates...
Change to Pfizer Static Chart

Fall of
--0.85 (+0.98%) Pfizer - [Ticker: PFE]Chart Pfizer  News Pfizer  Download Historical Prices for Metastock Pfizer and Others  Technical Analysis Pfizer  
Last Trade45.14Last Trade Time2018-12-04 - 00:00:00
Variation--0.85 (+0.98%)Open46.23
High46.47Low45.11
Volume26,062,310Average Volume (3m)0
YieldBid / Ask35.33 x 5,700 - 35.34 x 8,100
Former Close45.9952 Week Range[0.00 - 0.00]
PER0.00%EPS0.00
Ex-Dividend DateDividend Payment
Market Capitalization0 1 Year Price-Target0.00
Note: The data may have some minutes of delay.

 News about Pfizer [PFE]:   (ordered by relevance)
Viagra Sales Are Down. Here's Why Pfizer Maintains Its Market Lead Anyway  Fortune

Pfizer, maker of erectile dysfunction drug Viagra and its generic, maintains market dominance, even as Viagra (sildenafil) sales are down.

FiercePharmaAsia?AstraZeneca's China business; Pfizer Japan valsartan recall; Xofluza resistance  FiercePharma

AstraZeneca's China business soared 25% in 2018 as cancer and respiratory drugs pulled through; Pfizer Japan is recalling valsartan combo drugs made using ...

Pfizer Inc. (PFE) Position Trimmed by Fishman Jay A Ltd. MI  Fairfield Current

Fishman Jay A Ltd. MI decreased its position in shares of Pfizer Inc. (NYSE:PFE) by 0.6% during the third quarter, according to its most recent 13F filing with the ...

Pfizer's Next 3 Years: What Investors Can Expect  Motley Fool

After a great 2018, what's in store for Pfizer in 2019 and the next two years?

After Pfizer Ruling, Here Are Keys to Using Electronic Media to Present Binding Arbitration Policies | New Jersey Law Journal  Law.com

In the wake of an Appellate Division ruling invalidating Pfizer Inc.'s electronic distribution of a mandatory arbitration agreement to its workers, companies using ...

Toxic chemicals enter Kalamazoo River from Pfizer wastewater  MLive.com

KALAMAZOO, MI -- Toxic chemicals from a Pfizer facility entered the Kalamazoo River after passing through the city of Kalamazoo's wastewater system.

Pfizer Results Hurt by Pricing Challenges  The Wall Street Journal

Pfizer reported a fourth-quarter loss as the pharmaceutical company faced pricing challenges in the U.S. and tougher generic competition.

Pfizer's earnings outlook disappoints after Viagra loses patent protection and Lyrica faces same fate  CNBC

Pharmaceutical giant Pfizer braced investors for little-to-no revenue growth in 2019 after its blockbuster erectile dysfunction drug Viagra and others lost patent ...

Pfizer recalls contaminated high blood pressure drug in Japan  Seeking Alpha

Pfizer's (PFE) Japanese subsidiary is recalling more than 763K tablets of its hypertension drug Amvalo due to the presence of a carcinogen. The pills were.

Better Buy: Johnson & Johnson vs. Pfizer  Motley Fool

Healthcare has given investors great opportunities for a long while, and pharmaceutical specialists in particular have seen plenty of solid gains over time.

Pfizer pushes up price of birth control used by low-income women  CBC.ca

Sexual health clinics in southwestern Ontario that offer low-cost birth control say they've had to increase the price of a number of their products?sometimes by ...

Pfizer Biopharmaceuticals Group's Late-Stage Pipeline Looks Well Positioned  Seeking Alpha

Pfizer has been investing heavily in establishing a competitive pipeline of innovative medicines. In-market and innovative brands have driven performance but ...

Pfizer Looks To Move Tafamidis Forward With Priority Review  Seeking Alpha

Pfizer announced that it had submitted both NDA applications to receive FDA approval for tafamidis to treat patients with transthyretin amyloid cardiomyopathy.

Pfizer's Q4 Earnings And What Lies Ahead For The Company In 2019  Forbes

Pfizer (NYSE:PFE) recently posted its Q4 results, which were slightly above the street estimates. The company's overall sales grew 5%, while adjusted earnings ...

Pharma Company Pfizer to Partner With Government on Drug Resistance  The Wire

In a questionable move, the Indian government has tied up with Pfizer.

Pfizer (PFE) Q4 Earnings Beat, 2019 View Tepid, Stock Dips  Zacks.com

Pfizer's (PFE) fourth-quarter earnings and sales beat estimates. Its forecast for 2019 falls short of expectations. Stock dips 2% in pre-market trading.

Would Pfizer Shareholders Win With an Acquisition of Amarin?  The Motley Fool

A Pfizer buyout of Amarin is still just a rumor. But rumors sometimes turn into reality.

Union Bankshares Has Trimmed Its Pfizer (PFE) Stake by $452,056; Comerica Bank Holding In New Oriental Ed & Technology Gro (EDU) Was Has Upped  The Hi New Ulm

Union Bankshares Corp decreased its stake in Pfizer Inc (PFE) by 7.77% based on its latest 2018Q3 regulatory filing with the SEC. Union Bankshares Corp sold ...

Pfizer (PFE) Q4 Earnings & Sales Beat, 2019 View Disappoints  Zacks.com

Pfizer's (PFE) fourth-quarter earnings and sales beat estimates. 2019 forecast falls short of expectations. Stock dips 2% in pre-market.

3 Things You Should Expect in Pfizer's Q4 Earnings Update  The Motley Fool

Pfizer (NYSE:PFE) gave good news and bad news when it reported third-quarter results in October. The big drugmaker beat Wall Street's earnings estimates, but ...

Analyst Research and Recommendations: Pfizer Inc. (PFE), Verra Mobility Corporation (VRRM)  Analyst Journal

Pfizer Inc. (NYSE:PFE) tinted gains of +0.65% (+0.27 points) to US$41.97. The volume of 18.84 Million shares climbed down over an trading activity of 26.46 ...

Santa Barbara Asset Management Has Trimmed Pfizer (PFE) Position By $1.88 Million; HOCHSCHILD MINING PLC LONDON ORDINARY SH (HCHDF) Shorts Up By 1.08%  The Hi New Ulm

Santa Barbara Asset Management Llc decreased Pfizer Inc (PFE) stake by 0.97% reported in 2018Q3 SEC filing. Santa Barbara Asset Management Llc sold ...

Ramping up the expectation: Pfizer Inc. (PFE), Eli Lilly and Company (LLY)  FinBulletin

Since the start of this financial year stock price of the Pfizer Inc. (NYSE: PFE)has maneuvered across quite a bit, with a year-to-date change of -1.68. By taking a ...

Pfizer's Subpar Outlook Embodies Pharma's Plight  Bloomberg

The industry faces headwinds that may become only more acute as scrutiny over drug prices intensifies.

Pfizer: Still A Cash Cow  Seeking Alpha

Operational cash flows continue to increase. They continue to cover financing and investing activities. Remaining long. This idea was discussed in more depth ...

Pfizer (PFE) to Report Q4 Earnings: What's in the Cards?  Zacks.com

While Pfizer's (PFE) new drugs like Ibrance and Xeljanz are likely to drive Q4 sales, genericization of key drugs and weak sales in the EH segment will hurt the ...

Pfizer?s ?Promising Outlook? Still Shines for Analysts After Earnings Report  Barron's

Pfizer stock rose after the company's latest earnings report. Although Pfizer's full-year guidance is lower than the Street consensus, analysts are still excited ...

As Pfizer (PFE) Market Value Rose, Wms Partners Increased Its Position by $1.38 Million; Convergence Investment Partners Has Cut Its Marathon Pete (MPC) Position as Shares Declined  The Hi New Ulm

Wms Partners Llc increased its stake in Pfizer Inc (PFE) by 125.28% based on its latest 2018Q3 regulatory filing with the SEC. Wms Partners Llc bought 31321 ...

Pfizer Ireland to transfer 900 employees to new DC plan in April  Pensions & Investments

Pfizer Ireland will begin to transfer 900 employees into a new defined contribution plan from its defined benefit plans on April 1.

Pfizer, Merck drop after Wall Street downgrades on 'patent cliff' and competition  CNBC

Shares of Pfizer and Merck fell on Wednesday after Wall Street downgraded the drugmakers on increased competition and the loss of patent protection.

Pfizer braces for work stoppage after announcing it will switch the pensions of Irish holdouts  FiercePharma

After five years of negotiations, Pfizer has decided it's time to move employees at plants in Ireland to the same pension plans that the rest of the company's ...

Is There Some Concern About Pfizer Inc. (PFE), Titan Pharmaceuticals, Inc. (TTNP)  Post Analyst

One of the trending stocks on Thursday was Pfizer Inc. (NYSE:PFE). The number of shares transacted for the day under observation was 18843681 contracts.

Pfizer Stock Rises On Earnings Beat; Allergan Stock Dips On Weak Outlook  Investor's Business Daily

Pfizer earnings beat forecasts, but the firm gave weak guidance. Pfizer stock fell. Allergan earnings beat, but guidance was mixed. Allergan stock fell.

Better Buy: Pfizer vs. AbbVie  Motley Fool

Which of these dividend-paying pharmaceutical stocks is the best pick right now?

Pfizer shares slide 2% premarket after it swings to loss, guidance lags consensus  MarketWatch

Pfizer Inc. shares PFE, +1.27% slid 2% in premarket trade Tuesday, after the company posted a loss for the fourth quarter and offered guidance that was below ...

How to Trade Merck and Pfizer Pre-Earnings - Each Face Deteriorating Charts  TheStreet.com

Merck and Pfizer have been laggards so far in 2019. Technical warnings occurred on Dec. 4 when both set multiyear highs and both received downgrades.

Pharma Stock Roundup: Q4 Earnings, Pipeline Updates at PFE, RHHBY  Zacks.com

Pfizer (PFE), Allergan (AGN), AbbVie (ABBV) and Novartis (NVS) report Q4 results.

Why GSK and Pfizer are spinning out their consumer-health business  Business Insider

British drugmaker GlaxoSmithKline in December 2018 laid out plans to combine its consumer-health business with Pfizer's and then spin out the new company.

Pfizer Inc. (PFE) predicted to reach $44.54 in coming one year period  Voice Of Analysts

Pfizer Inc. (PFE) stock managed performance 0.65% over the last week and switched with performance of -1.78% throughout past one month period. The stock ...

Pfizer Inc. (PFE) Boasting a VC1 Score of 31  Richland Standard

Pfizer Inc. (PFE) currently has a Value Composite score of 31. The Value Composite One (VC1) is a method that investors use to determine a company's.

Pfizer (PFE) Tops Q4 EPS by 1c, FY EPS Guidance Misses Consensus  StreetInsider.com

Pfizer (NYSE: PFE) reported Q4 EPS of $0.64, $0.01 better than the analyst estimate of $0.63. Revenue for the quarter came in at $13.98 billion versus the ...

Pfizer closes on EU approval of lung cancer drug Vizimpro  PMLiVE

Among the clutch of decisions at the last CHMP meeting was a recommendation for approval of Pfizer's Vizimpro, an EGFR-targeting drug that could challenge ...

Bayer, Pfizer trim jobs  Chemical & Engineering News

In a move that will cost nearly 700 jobs, Bayer will wind down operations at its Robinson, Pennsylvania, site over the next two years. The 569 full-time employees ...

EMD Seron, Pfizer (PFE) Announce FDA Accepted sBLA and Granted Priority Review for BAVENCIO Plus INLYTA for Treatment of Advanced RCC  StreetInsider.com

EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany in the US and Canada, and Pfizer Inc. (NYSE: PFE) today announced that ...

Pfizer beats Q4 consensus, shares down 3% premarket on soft guidance  Seeking Alpha

Pfizer (PFE) Q4 results: Revenues: $13,976M (+2.0%); Innovative Health: $8,852M (+7.7%); Essential Health: $5,124M (-6.6%). Internal Medicine: $2,657M ...

Siptu defers Pfizer strike action in row over pensions  The Irish Times

Workplace Relations Commission invites both sides to talks to avert strike action that had been due to start on Friday.

Pharma Stock Roundup: Regulatory Updates in Focus at PFE, BMY, RHHBY, SNY  Zacks.com

Pfizer's (PFE) tafamidis application gets FDA's priority review. Regulatory updates for Roche's (RHHBY) and Bristol-Myers'(BMY) cancer combination drugs in ...

How Much of Pfizer Inc. (NYSE:PFE) Is in Your Portfolio? Target Weight Stands at 0.04840  Preston Business Review

When investors are recalibrating their portfolios they should take a look at current volatility levels and the target weight calculation of a given stock. Pfizer Inc.

Barry Investment Advisors Has Cut Its Pfizer (PFE) Position by $3.08 Million as Shares Rose; As Jpmorgan Chase & Company (JPM) Share Price Declined, Shareholder Cove Street Capital Cut Its Position  The Yomi Blog

Barry Investment Advisors Llc decreased its stake in Pfizer Inc (PFE) by 24.23% based on its latest 2018Q3 regulatory filing with the SEC. Barry Investment Cove ...

Shares in the Spotlight: Pfizer Inc. (NYSE:PFE)  Richland Standard

Checking in on some recent market action, we have noted that shares of Pfizer Inc. (NYSE:PFE) have been seen trading around the $41.97 mark. Investors ...

Epoprostenol Market 2019-2026 Trends by Top Players: Pfizer, Cipla, Sanofi, Bayer HealthCare, GlaxoSmithKline - Press Release  Digital Journal

The Epoprostenol report divides the market of potential buyers into different groups, or segments/sub segments, based on various characteristics. This press ...

A former Pfizer employee wins right to sue, raising questions on arbitration  STAT

Amy Skuse maintained she was fired because she refused to receive a yellow fever vaccine, which went against her religious beliefs as a Buddhist.

Pfizer (PFE) Holder Kempner Capital Management Has Decreased Position by $1.34 Million; Boussard & Gavaudan Investment Management Llp Trimmed Its Position in Alibaba Group Hldg LTD (BABA) as Stock Declined  The Hi New Ulm

Kempner Capital Management Inc decreased its stake in Pfizer Inc. (PFE) by 53.57% based on its latest 2018Q3 regulatory filing with the SEC. Kempner Capital ...

Do You Have This Stock in Portfolio?: Pfizer Inc. (PFE), Green Plains Inc. (GPRE)  News Stays On Track

Pfizer Inc. (PFE) Daily Performance: Pfizer Inc. (PFE) stock negotiated recent volume of 18847248 shares in recent trading session on Thursday Dated ...

Taylor Frigon Capital Management Increases Stake in Radcom LTD (RDCM); Pfizer (PFE) Stock Price Rose While Jacobs & Co Lowered Stake  The FinHeadLines

Taylor Frigon Capital Management Llc increased its stake in Radcom Ltd. (RDCM) by 114.04% based on its latest 2018Q3 regulatory filing with the SEC. Taylor ...

India- Erectile Dysfunction Drugs Market Growth Dominated Pfizer Inc.: By Size, Drivers, Share And Forecast To 2023  MENAFN.COM

(MENAFN - GetNews) MRFR is the Leading Brand in The Research Company who Recently Published Erectile Dysfunction Drugs Market Research Reports ...

What to Watch at This Week's Cancer Summit: Nektar, Merck, Pfizer Data  Bloomberg

Investors are preparing for the release of key clinical-development data at the American Society of Clinical Oncology's three-day Genitourinary Cancers ...

Health Care Sector Update for 02/15/2019: AKAO, ORPN, CGC, JNJ, PFE, ABT, MRK, AMGN  Nasdaq

Top Health Care Stocks: JNJ: Flat PFE: +0.02% ABT: Flat MRK: +0.20% AMGN: Flat Health care stocks were flat to higher pre-bell Friday. Early movers.

The Most Important Things To Watch in FireEye, Inc. (FEYE) and Pfizer Inc. (PFE)  Post Analyst

Volume for FireEye, Inc. (NASDAQ:FEYE) decreased on 02/12/19 and the net result is a 0.11 gain from the open. The stock closed with a volume of 8420271 ...

Uniqure turns the screw on Spark and Pfizer  Vantage

After a disastrous day for gene therapy yesterday, Uniqure is flying the flag for the sector with its haemophilia B gene therapy candidate AMT-061. The group's ...

Podcast: Kenyon and Berrahoui on the pitfalls of PFE  Risk.net

Chris Kenyon, head of XVA quant modelling at MUFG Securities for Europe, the Middle East and Africa, and Mourad Berrahoui, head of counterparty credit risk ...

Global Hemostats Market Emerging Trends And Technology 2024 Ethicon US LLC, Pfizer Inc., and CR Bard Inc., B.Braun Melsungen, 3-D Matrix, Ltd., Resorba Medical GmbH, Anika Therapeutics, Inc., Arch Therapeutics Inc.  Honest Version

Global Hemostats Market Segmentation, By Product Type (Thrombin Based, Combination, Oxidized Regenerated Cellulose Based, Gelatin Based, Collagen ...

Pfizer (PFE) Holder Mai Wealth Advisors Has Cut Its Position as Share Value Rose; As Public Svc Enterprise Group Com (PEG) Market Value Rose, Holder Girard Partners LTD Has Cut Its Position by $463,008  The Hi New Ulm

Mai Wealth Advisors decreased its stake in Pfizer Inc (PFE) by 9.53% based on its latest 2018Q3 regulatory filing with the SEC. Mai Wealth Advisors sold 10094 ...

Bb&T (BBT) Stock Declined While Cypress Capital Management Has Increased by $868,560 Its Holding; Donaldson Capital Management Lifted Holding in Pfizer Com (PFE) by $906,884 as Stock Value Rose  The Hi New Ulm

Cypress Capital Management Llc increased its stake in Bb&T Corporation (BBT) by 9.82% based on its latest 2018Q3 regulatory filing with the SEC. Cypress ...

Market Focus: Pfizer Inc. (NYSE:PFE), Citigroup Inc. (NYSE:C) Valuation Review & Update  Richland Standard

The ERP5 Rank is an investment tool that analysts use to discover undervalued companies. The ERP5 looks at the Price to Book ratio, Earnings Yield, ROIC.

Pfizer cuts five biosimilars candidates and 150 jobs  BioPharma-Reporter.com

Pfizer has chosen to drop five biosimilar candidates and 150 jobs to divert the funds into developing its late-stage pipeline. The decision was made after an ...

Hundreds of new jobs could come to former Pfizer plant site  WPTZ

The cinder blocks, insulation and metal that once held up part of the Pfizer plant in Rouses point are now rubble. Demolition of the property is underway less ...

Veeva Systems (VEEV) Shareholder Glynn Capital Management Trimmed Holding; Pfizer (PFE) Shareholder Wms Partners Has Increased Stake by $1.38 Million as Share Price Rose  The Hi New Ulm

Glynn Capital Management Llc decreased its stake in Veeva Systems Inc. (VEEV) by 19.88% based on its latest 2018Q3 regulatory filing with the SEC. Glynn ...

North America Injectable Drug Delivery Market : By Top Ten Key Players: Pfizer Inc., Baxter, Gerresheimer AG. Terumo Corporation, Sandoz, Bespak, Teva Pharmaceutical Industries Ltd., B.Braun, Sun Pharma  Bitcoin Journal

North America Injectable Drug Delivery Market Segmentation, Type (Injectable Drug Delivery Devices, Injectable Drug Delivery Formulation), Application ...

FDA warned of EpiPen complaint problems at Pfizer's Meridian factories  Business Insider

Consumer complaints about EpiPens were increasing, but its manufacturer wasn't properly looking into those complaints, FDA inspectors warned in 2014.

As Bank Amer (BAC) Shares Declined, Stifel Financial Increased Position; Montrusco Bolton Investments Has Cut Its Pfizer (PFE) Stake by $1.99 Million; Stock Price Rose  The Yomi Blog

Stifel Financial Corp increased its stake in Bank Amer Corp (BAC) by 1.48% based on its latest 2018Q3 regulatory filing with the SEC. Stifel Financial Corp ...

Global Inflammatory Bowel Disease Treatment Market Outlook 2019-2027 : AbbVie, Inc., Pfizer, Inc., Allergan plc., Shire Plc, Novartis AG  Honest Version

Reportsbuzz added a new latest industry research report that focuses on Inflammatory Bowel Disease Treatment market and provides in-depth Global ...

Novartis AG (NVS)'s Financial Results Comparing With Pfizer Inc. (NYSE:PFE)  Lives Advice

This is a contrast between Novartis AG (NYSE:NVS) and Pfizer Inc. (NYSE:PFE) based on their risk, analyst recommendations, profitability, dividends,

Global Collagenase 3 Market Outlook 2019-2027 : Paradigm Biopharmaceuticals Ltd, Pfizer Inc, Takeda Pharmaceutical Co Ltd  Honest Version

Reportsbuzz added a new latest industry research report that focuses on Collagenase 3 market and provides in-depth Global Collagenase 3 market analysis ...

Veritas Asset Management Llp Raised Its Pfizer (PFE) Stake; Shareholder Yhb Investment Advisors Has Increased Mccormick & Co (MKC) Stake  Port Courier

Veritas Asset Management Llp increased its stake in Pfizer Inc (PFE) by 3.77% based on its latest 2018Q3 regulatory filing with the SEC. Veritas Asset Yhb ...

Revenue Estimates Analysis: Southwestern Energy Company (SWN), Pfizer Inc. (PFE)  MONReport

Southwestern Energy Company (NYSE: SWN) experienced a high price of $4.13 with a low value of $4 at the end of the last trading session, which followed after ...

Pfizer (PFE) Shareholder New England Professional Planning Group Trimmed Its Holding by $338,712; Brookstone Capital Management Decreased Its Aes (AES) Position by $595,465; Stock Value Rose  The FinHeadLines

New England Professional Planning Group Inc decreased its stake in Pfizer Inc (PFE) by 3.43% based on its latest 2018Q3 regulatory filing with the SEC.

Global Oncology Biosimilars Market Outlook 2019-2027 : Celltrion Inc., Pfizer Inc., Biocon, BIOCAD, Apotex Inc.  Honest Version

The report on the global ?Oncology Biosimilars market? offers detailed data on the Oncology Biosimilars market. Elements such as dominating companies, ...

New England Professional Planning Group Has Decreased Its Position in Pfizer (PFE) by $338,712; Srb Position in Plains All Amer Pipeline LP (PAA) Lowered by $4.13 Million  Lives Advice

New England Professional Planning Group Inc decreased its stake in Pfizer Inc (PFE) by 3.43% based on its latest 2018Q3 regulatory filing with the SEC.

Pfizer: 'Dropped preclinical programs do not change commitment to biosimilars'  BioProcess Insider

In the latest example of a Big Biopharma reducing its biosimilar presence, Pfizer has abandoned five of its preclinical programs. The decision is part of an R&D ...

Pfizer (PFE) Position Boosted by Adell Harriman & Carpenter Inc; Citi Trends (CTRN) Holder Northpointe Capital Has Increased Holding by $1.61 Million as Share Price Declined  Lives Advice

Adell Harriman & Carpenter Inc increased its stake in Pfizer Inc (PFE) by 1.64% based on its latest 2018Q3 regulatory filing with the SEC. Adell Harriman ...

Nxstage Medical (NXTM) Holder Alpine Partners Vi Has Trimmed Its Position; Pfizer (PFE) Shareholder Hgk Asset Management Has Lowered Its Holding as Stock Value Rose  Th? M?n?t?r

Alpine Partners Vi Llc decreased its stake in Nxstage Medical Inc (NXTM) by 12.74% based on its latest 2018Q3 regulatory filing with the SEC. Alpine Partners ...

M&T Bank Has Boosted Its Pfizer (PFE) Position by $171.95 Million as Share Price Rose; Mark Sheptoff Financial Planning Lowered Its Bristol Myers Squibb Co (BMY) Position by $492,636  The FinHeadLines

M&T Bank Corp increased its stake in Pfizer Inc (PFE) by 7975612.24% based on its latest 2018Q3 regulatory filing with the SEC. M&T Bank Corp bought 3.91M ...

As Pfizer (PFE) Valuation Rose, Holder Daiwa Sb Investments LTD Decreased by $405,240 Its Stake; As Maxim Integrated Products (MXIM) Share Price Declined, American National Insurance Company Lowered Its Holding  Port Courier

Daiwa Sb Investments Ltd decreased its stake in Pfizer Inc (PFE) by 89.42% based on its latest 2018Q3 regulatory filing with the SEC. Daiwa Sb Investments Ltd ...

Pfizer Receives Positive CHMP Opinion for VizimproŽ (dacomitinib) for the First-line Treatment of Adult Patients with Locally Advanced Or Metastatic Non-Small Cell Lung Cancer with EGFR-Activating Mutations  Associated Press

NEW YORK--(BUSINESS WIRE)--Feb 1, 2019--Pfizer today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European ...

New Jersey appeals court rules against Pfizer's arbitration clause  JURIST

The Superior Court of New Jersey, Appellate Division on Wednesday ruled that Pfizer's method of obtaining employee agreement to arbitration was inadequate.

Top Key Players of Chemotherapy Market | Pfizer Inc., Eli Lilly & Company, ImClone Systems Inc., GlaxoSmithKline, AstraZeneca, Schering-Plough by the end of 2023  openPR

According to the analysis offered by Market Research Future (MRFR), the global chemotherapy market has been presumed to strike a CAGR of 6.2% during the ...

3 Reasons Why Pfizer's Latest Dividend Hike Is Better Than You Might Think  The Motley Fool

Pfizer's 6% dividend increase is good news. But here's what makes it even better.

Affinivax, Astellas begin clinical quest to beat Pfizer's Goliath with a new kind of pneumococcal vaccine  Endpoints News

Days after the FDA blessed Merck's effort to challenge Pfizer's mega-blockbuster Prevnar 13 with a breakthrough designation, Affinivax is making the leap into ...

Doctor payments drove scripts for cancer drugs from Pfizer, Novartis and more: study  FiercePharma

Critics often target physicians who receive money from pharma, but the exact influence those payments have on prescribing is up for debate. In oncology, at ...

Global Gabapentin Market Consumption 2019 ? Depomed, Pfizer, Sun Pharmaceutical  Honest Version

Global Gabapentin Market 2019-2026 report is a professional and in-depth study on the market overview, market dynamics, competitive analysis, and leading ...

Global Pain Therapeutics Market Report 2019: 2018 Patent Expiry of Pfizer's Lyrica (pregablin) Contributed Towards Market Revenue Loss  PRNewswire

DUBLIN, Feb. 14, 2019 /PRNewswire/ -- The "The Global Pain Therapeutics Market, 6th Edition: Market Trends & R&D Insights" report has been added to...

Endometriosis Market Analysis (2019 - 2025): AbbVie, AstraZeneca, Bayer HealthCare, Pfizer, Addex Therapeutics - Press Release  Digital Journal

Neurocrine BiosciencesThe scope of the Report:Get a detailed segmentation of the global Endometriosis market according to the type of product and application ...

Garrison Financial Corp Takes Position in Pfizer Inc. (NYSE:PFE)  Modern Readers

Garrison Financial Corp purchased a new stake in Pfizer Inc. (NYSE:PFE) during the third quarter, according to its most recent filing with the Securities ...

Global Antivenom Market 2019 ? BTG Plc, Pfizer, Haffkine Bio-Pharmaceutical Corporation  Honest Version

This new report by Eon Market Research, titled ?Global Antivenom Market 2019 Research Report, 2015 ? 2025? offers a comprehensive analysis of Antivenom ...

Technical Indicator Watch on Shares of Pfizer Inc (PFE) as Pivot Hits $41.9  Augusta Review

Watching some technical levels for Pfizer Inc (PFE), we have noticed that the current 20-Day Bollinger Bands signal is reading Hold. This indicator may be used.

The Better Stock Is Still Crystal Clear: Boston Scientific Corporation (BSX), Pfizer Inc. (PFE)  GV Times

The stock of Boston Scientific Corporation (NYSE:BSX) witnessed a 54.95% increase from the 52-week low price of $25.84 it recorded on 2018-02-13.

Global Breast Cancer Treatment Drugs Market 2019-2025 Abbvie, Abbott, Novartis, Pfizer  Honest Version

This report focuses on Breast Cancer Treatment Drugs Market 2019-2025 volume and value at global level, regional level and company level. From a global ...

Pfizer Ltd. - Loss of Share Certificate / Issue of Duplicate Share Certificate  The Hindu BusinessLine

Pfizer Ltd has informed BSE regarding Loss of Share Certificate / Issue of Duplicate Share Certificate. Pdf Link: Pfizer Ltd. - Loss of Share Certificate / Issue of ...

Grisanti Capital Management LLC Trims Holdings in Pfizer Inc. (PFE)  PressOracle

Grisanti Capital Management LLC trimmed its stake in Pfizer Inc. (NYSE:PFE) by 95.2% during the third quarter, according to its most recent disclosure with the ...

For more news about Pfizer click here:
Pfizer News 

Search the Internet:

Website Width:
Bookmark and Share

 Background image:

Copyright@2010-2019 - TR4DER.com, all rights reserved.
Investment Forum Stock Quotes Investment News Investment Chat Disclaimer Webmaster Resources